Get started
Author

Mae Sheikh‐Ali

Observed names: M. Sheikh-Ali, Mae Sheikh-Ali, Sheikh-Ali, M.
OpenAlex ID: A5006862514
Can Serum β-Hydroxybutyrate Be Used to Diagnose Diabetic Ketoacidosis?
2008 · Mae Sheikh-Ali, Brad S. Karon, et al. · Diabetes Care · 180
PDF
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
2024 · George L. Bakris, Manish Saxena, et al. · JAMA · 138
PDF
The Antioxidant Paradox in Diabetes Mellitus
2010 · Mae Sheikh-Ali, Joe M Chehade, et al. · American Journal of Therapeutics · 72
Hyperglycemia-induced endoplasmic reticulum stress in endothelial cells
2010 · Mae Sheikh-Ali, Senan Sultan, et al. · Nutrition · 68
Effects of antioxidants on glucose-induced oxidative stress and endoplasmic reticulum stress in endothelial cells
2009 · Mae Sheikh-Ali, Senan Sultan, et al. · Diabetes Research and Clinical Practice · 47
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
2025 · Akshay S. Desai, Adam D. Karns, et al. · JAMA · 46
Estrogen-dependent inhibition of dextrose-induced endoplasmic reticulum stress and superoxide generation in endothelial cells
2012 · Michael J. Haas, Prafull Raheja, et al. · Free Radical Biology and Medicine · 39
The Role of Micronutrients in Managing Diabetes
2009 · Joe M. Chehade, Mae Sheikh-Ali, et al. · Diabetes Spectrum · 39
A Review of the Efficacy and Tolerability of Bempedoic Acid in the Treatment of Hypercholesterolemia
2020 · Stephanie Niman, Khyatiben Rana, et al. · American Journal of Cardiovascular Drugs · 36
A Review on the Efficacy and Safety of Oral Semaglutide
2021 · Stephanie Niman, Jennifer Hardy, et al. · Drugs in R&D · 35
PDF
Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin
2017 · Mark L. Warren, Louis B. Chaykin, et al. · Clinical Diabetes · 19
Role of Vitamin D in the Onset, Progression, and Severity of Multiple Sclerosis
2012 · Sandra Mesliniene, Laurie Ramrattan, et al. · Endocrine Practice · 18
A Critical Review of Icosapent Ethyl in Cardiovascular Risk Reduction
2023 · Jessica Huston, Hannah Schaffner, et al. · American Journal of Cardiovascular Drugs · 16
PDF
Medical Management and Strategies to Prevent Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus
2013 · Mae Sheikh-Ali, Prafull Raheja, et al. · Postgraduate Medicine · 14
Circadian clock desynchronisation and metabolic syndrome
2014 · Mae Sheikh-Ali, Jaisri Maharaj · Postgraduate Medical Journal · 12
Inhibition of apolipoprotein A-I gene by the aryl hydrocarbon receptor: A potential mechanism for smoking-associated hypoalphalipoproteinemia
2012 · Emad Naem, Rosalyn Alcalde, et al. · Life Sciences · 11
Insulin icodec: A novel once‐weekly treatment for diabetes
2024 · Hannah Schaffner, Jordyn Wiener, et al. · Diabetic Medicine · 9
A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data
2019 · Khyatiben Rana, Jessica Reid, et al. · Diabetes Metabolic Syndrome and Obesity · 8
PDF
25-Hydroxyvitamin D Levels and Acute Cellular Rejection in Liver Transplant Patients
2014 · Mae Sheikh-Ali, Andrew P. Keaveny, et al. · Endocrine Practice · 8
Predicting the Development of Cushing's Syndrome in Medullary Thyroid Cancer: Utility of Proopiomelanocortin Messenger Ribonucleic Acid In Situ Hybridization
2007 · Mae Sheikh-Ali, Murli Krishna, et al. · Thyroid · 8
Unexpected Bone Metastases from Thyroid Cancer
2015 · Sandra Gibiezaite, Savas Ozdemir, et al. · Case Reports in Endocrinology · 7
PDF
Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention
2020 · Jessica Reid, Khyatiben Rana, et al. · American Journal of Cardiovascular Drugs · 6
The effect of healthcare provider education on diabetes management of hospitalised patients
2010 · J. M. Chehade, M. Sheikh-Ali, et al. · International Journal of Clinical Practice · 6
Danuglipron. Glucagon-like peptide 1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity
2022 · Alexander J. Sperry, Jennifer Hardy, et al. · Drugs of the Future · 5
Efpeglenatide. Glucagon-like peptide 1 (GLP-1) receptor agonist, Treatment for type 2 diabetes
2019 · Reid, J., Rana, K., et al. · Drugs of the Future · 5
Works count: 30
Citation count: 854
H-index: 14
I10-index: 16
Year
Topic
Type